| 英文名称 |
中文名称 |
CAS号 |
操作 |
| VAS 3947 |
VAS3947 |
869853-70-3 |
详细
|
| BTR-1 |
BTR-1 |
18331-34-5 |
详细
|
| IACS-010759 |
5-(5-甲基-1-(3-(4-(甲基磺酰基)哌啶-1-基)苄基)-1H-1,2,4-三唑-3-基)-3-(4-(三氟甲氧基)苯基)-1,2,4-恶二唑 |
1570496-34-2 |
详细
|
| Unesbulin |
PTC596 |
1610964-64-1 |
详细
|
| Zotatifin |
Zotatifin |
2098191-53-6 |
详细
|
| MIK665 |
S64315(MIK665) |
1799631-75-6 |
详细
|
| C188-9 |
432001-19-9 |
432001-19-9 |
详细
|
| AZD4320 |
AZD4320 |
1357576-48-7 |
详细
|
| dBET6 |
1950634-92-0 |
1950634-92-0 |
详细
|
| Tubulin inhibitor 1 |
TUBULIN INHIBITOR 1 |
2237054-53-2 |
详细
|
| Sparfosic acid trisodium |
Sparfosic acid trisodium |
70962-66-2 |
详细
|
| S130 |
化合物 T12819 |
1160852-22-1 |
详细
|
| TL02-59 |
3-(6,7-dimethoxyquinazolin-4-yloxy)-N-(4-((4-ethylpiperazin-1-yl)methyl)-3-(trifluoromethyl)phenyl)-4-methylbenzamide |
1315330-17-6 |
详细
|
| IITZ-01 |
IITZ-01 |
1807988-47-1 |
详细
|
| CVT-11127 |
N-[2-[6-[[(3,4-二氯苯基)甲基]氨基]-2-(4-甲氧基苯基)-3-氧代-3,4-二氢吡啶并[2,3-B]吡嗪-4-基]乙基]乙酰胺 |
1018674-83-3 |
详细
|
| Cantrixil |
CANTRIXIL |
2135511-22-5 |
详细
|
| BT2 |
3,6-二氯-2-苯并噻吩羧酸 |
34576-94-8 |
详细
|
| LCS-1 |
4,5-二氯-2-(3-甲苯基)哒嗪-3-酮 |
41931-13-9 |
详细
|
| BCL6-IN-7 |
化合物 T8731 |
2097518-46-0 |
详细
|
| SKI-I |
化合物 SKI-I |
306301-68-8 |
详细
|
| S55746 |
化合物S55746 |
1448584-12-0 |
详细
|
| TJ191 |
化合物TJ191 |
1522415-97-9 |
详细
|
| TW-37 |
N-[4-(2-叔丁基苯磺酰基)苯基]-2,3,4-三羟基-5-(2-异丙基苯基甲基)苯甲酰胺 |
877877-35-5 |
详细
|
| T-1101 tosylate |
TAI-95 tosylate |
2250404-95-4 |
详细
|
| TVB-3166 |
TVB-3166 |
1533438-83-3 |
详细
|
| Volasertib |
N-[反式-4-[4-(环丙基甲基)-1-哌嗪基]环己基]-4-[[(7R)-7-乙基-5,6,7,8-四氢-5-甲基-8-异丙基-6-氧代-2-蝶啶基]氨基]-3-甲氧基苯甲酰胺 |
755038-65-4 |
详细
|
| CLZ-8 |
MCL1-IN-8 |
678158-55-9 |
详细
|
| E64FC26 |
E64FC26 |
2285446-62-8 |
详细
|
| BTSA1 |
CS-2853 |
314761-14-3 |
详细
|
| A-1210477 |
A-1210477 |
1668553-26-1 |
详细
|
| ISRIB (trans-isomer) |
ISRIB(TRANS-ISOMER) 抑制剂 |
1597403-47-8 |
详细
|
| Pyridoclax |
Pyridoclax |
1651890-44-6 |
详细
|
| MPI-0479605 |
N6-环己基-N2-(2-甲基-4-吗啉苯基)-9H-嘌呤-2,6-二胺 |
1246529-32-7 |
详细
|
| FB23-2 |
FB23-2 |
2243736-45-8 |
详细
|
| ML141 |
ML 141 |
71203-35-5 |
详细
|
| Lisaftoclax |
Bcl-2/Bcl-xl inhibitor 1 |
2180923-05-9 |
详细
|
| CCT369260 |
|
2647503-57-7 |
详细
|
| SD-36 |
SD-36 |
2429877-44-9 |
详细
|
| MCL-1/BCL-2-IN-2 |
MCL-1/BCL-2-IN-2 |
2163793-44-8 |
详细
|
| MCL-1/BCL-2-IN-3 |
MCL-1/BCL-2-IN-3 |
2163793-55-1 |
详细
|
| DCZ0415 |
DCZ0415 |
2242470-43-3 |
详细
|
| Cobimetinib |
考比替尼 |
934660-93-2 |
详细
|
| Desmorpholinyl Navitoclax-NH-Me |
化合物DESMORPHOLINYL NAVITOCLAX-NH-ME |
2365172-82-1 |
详细
|
| STM2457 |
STM2457 |
2499663-01-1 |
详细
|
| Batabulin |
Unii-T4np8G3K6q |
195533-53-0 |
详细
|
| Polyinosinic-polycytidylic acid sodium |
双链聚肌胞 |
42424-50-0 |
详细
|
| BCL6-IN-5 |
BCL6-IN-5 |
2253878-09-8 |
详细
|
| MK-8745 |
MK8745 |
885325-71-3 |
详细
|
| S65487 |
S-65487 |
1644600-79-2 |
详细
|
| S65487 hydrochloride |
S65487 HYDROCHLORIDE |
1644543-95-2 |
详细
|
| PFI-90 |
N'-(吡啶-2-基)吡啶-2-甲酰肼 |
53995-62-3 |
详细
|
| 1A-116 |
1A-116 |
1430208-73-3 |
详细
|
| Niraparib |
尼拉帕尼 |
1038915-60-4 |
详细
|
| CCT 137690 |
甲磺酸阿贝西尼 |
1095382-05-0 |
详细
|
| NS3694 |
NS 3694 |
426834-38-0 |
详细
|
| RWJ-56110 dihydrochloride |
RWJ-56110 DIHYDROCHLORIDE |
2387505-58-8 |
详细
|
| BI-3802 |
顺式-2-((6-((5-氯-2-(3,5-二甲基哌嗪-1-基)嘧啶-4-基)氨基)-1-甲基-2-氧代-1,2-二氢喹啉-3-基)氧基)-N-甲基乙酰胺 |
2166387-65-9 |
详细
|
| Deoxynyboquinone |
化合物 T27148 |
96748-86-6 |
详细
|
| BI-3812 |
CPD1815 |
2166387-64-8 |
详细
|
| Pitstop 2 |
化合物PITSTOP 2 |
1419320-73-2 |
详细
|
| Angiotensin II human TFA |
|
2761969-44-0 |
详细
|
| Palomid 529 |
PALOMID 529 (P529) |
914913-88-5 |
详细
|
| Amsilarotene |
4-[[3,5-二(三甲基硅烷基)苯甲酰基]氨基]苯甲酸 |
125973-56-0 |
详细
|
| (S)-Thalidomide |
(-)-沙利度胺 |
841-67-8 |
详细
|
| Rohinitib |
|
1139253-73-8 |
详细
|
| BAM7 |
BAM7 |
331244-89-4 |
详细
|
| Devimistat |
6,8-双(苄硫基)辛酸 |
95809-78-2 |
详细
|
| (S)-Gossypol (acetic acid) |
1189561-66-7 |
1189561-66-7 |
详细
|
| AZD1208 |
AZD1208 |
1204144-28-4 |
详细
|
| Maritoclax |
(±)-MARINOPYRROLE A |
1227962-62-0 |
详细
|
| Flupentixol dihydrochloride |
盐酸氟哌噻吨 |
2413-38-9 |
详细
|
| Cilengitide |
西仑吉肽 |
188968-51-6 |
详细
|
| INH1 |
N-[4-(2,4-二甲基苯基)-2-噻唑基]苯甲酰胺 |
313553-47-8 |
详细
|
| Prexasertib dihydrochloride |
CHK1抑制剂 |
1234015-54-3 |
详细
|
| UMI-77 |
UMI-77 |
518303-20-3 |
详细
|
| GSK2795039 |
1415925-18-6 |
1415925-18-6 |
详细
|
| MM-401 TFA |
|
1442106-11-7 |
详细
|
| JX06 |
4,4'-(dithiodicarbonothioyl)dimorpholine |
729-46-4 |
详细
|
| A-1155463 |
醋酸艾塞那肽 |
1235034-55-5 |
详细
|
| A-1331852 |
A-1331852 |
1430844-80-6 |
详细
|
| BMS-202 |
PD1-PDL1抑制剂2 |
1675203-84-5 |
详细
|
| Navitoclax-piperazine |
ABT-263-piperazine |
2143096-93-7 |
详细
|
| TCS7010 |
Aurora A Inhibitor I |
1158838-45-9 |
详细
|
| Perphenazine-d4 |
奋乃静D4 |
155593-75-2 |
详细
|
| Ketoprofen-d3 |
酮洛芬D3 |
159490-55-8 |
详细
|
| Meloxicam-d3 |
三氘代美洛昔康 |
942047-63-4 |
详细
|
| Mangafodipir trisodium |
锰福地吡三钠 |
140678-14-4 |
详细
|
| Vincristine-d3-ester (sulfate) |
[2H3]-长春新碱硫酸盐 |
1217854-24-4 |
详细
|
| Tetracosane-d50 |
氘代正二十四烷 |
16416-32-3 |
详细
|
| Cyclo(Arg-Gly-Asp-D-Phe-Val) TFA |
199807-33-5 |
199807-33-5 |
详细
|
| 3BDO |
3BDO, MTOR激酶激活剂, 自噬抑制剂 |
890405-51-3 |
详细
|
| 2'-O-Methylguanosine |
2'-甲氧基鸟苷 |
2140-71-8 |
详细
|
| Tributyrin |
三丁酸甘油酯 |
60-01-5 |
详细
|
| Monomethyl auristatin E |
一甲基澳瑞他汀 E |
474645-27-7 |
详细
|
| Taltobulin |
N,BETA,BETA-三甲基-L-苯基丙氨酰基-N-[(1S,2E)-3-羧基-1-(1-甲基乙基)-2-丁烯基]-N,3-二甲基-L-缬氨酰胺 |
228266-40-8 |
详细
|
| KS106 |
化合物 KS106 |
2408477-50-7 |
详细
|
| Disulfiram |
二硫化四乙基秋兰姆 |
97-77-8 |
详细
|
| ARD-61 |
|
2316837-08-6 |
详细
|
| (S)-Verapamil hydrochloride |
S-维拉帕米 |
36622-28-3 |
详细
|
| KEA1-97 |
KEA1-97 |
2138882-71-8 |
详细
|